Nonalcoholic steatohepatitis: Cirrhosis, hepatocellular carcinoma, and burnt-out NASH

Journal of Gastroenterology

Volumn 39, Issue 12, 2004, Pages 1215-1218

  Yoshioka, Yoko ^a   Hashimoto, Etsuko ^a   Yatsuji, Satoru ^a   Kaneda, Hiroyuki ^a   Taniai, Makiko ^a   Tokushige, Katsutoshi ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Burnt out NASH; Cirrhosis; Cryptogenic cirrhosis; Hepatocellular carcinoma; NASH

Indexed keywords

INSULIN; IRON;

AGED; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOPSY; CANCER INVASION; CASE REPORT; CLINICAL FEATURE; DEATH; DEGENERATION; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES; FEMALE; FUNCTIONAL ASSESSMENT; HEMATEMESIS; HOMEOSTASIS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; IRON OVERLOAD; LIGATION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER NECROSIS; MALLORY BODY; METABOLIC DISORDER; MULTIPLE CANCER; NONALCOHOLIC FATTY LIVER; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS HEPATITIS;

AGED; CARCINOMA, HEPATOCELLULAR; FATAL OUTCOME; FATTY LIVER; FEMALE; HUMANS; LIVER NEOPLASMS;

EID: 11344275293     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-004-1475-x     Document Type: Article

References (26)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc 1980;55:434-8.
2. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003;37:1202-19.
3. American Gastroenterological Association medical position statement: Nonalcoholic fatty liver disease. Gastroenterology 2002;123:1702-4.
4. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705-25.
5. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-30.
6. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, Cullough AJ. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-9.
7. Cortez-Pinto H, Baptista A, Camilo ME, Carneiro M. Nonalcoholic steatohepatitis - a long-term follow-up study. Dig Dis Sci 2003;48:1909-3.
8. Propst A, Propst T, Judmaier G, Vogel W. Prognosis in nonalcoholic steatohepatitis. Gastroenterology 1995;108:1607.
9. Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003;38:420-7.
10. Harrison SA, Torgerson S, Hayashi PH. The natural history of nonalcoholic fatty liver disease: A clinical histopathological study. Am J Gastroenterol 2003;98:2042-7.
11. Ong JP, Younossi ZM. Nonalcoholic fatty liver disease (NAFLD) - two decades later: Are we smarter about its natural history? Am J Gastroenterol 2003;98:1915-7.
12. Alvarez E, Dominguez N, Landeira G, et al. Expanding knowledge on natural history of nonalcoholic steatohepatitis: A longitudinal study of sequential liver biopsies (abstract). Hepatology 2003;38(Suppl 1):231.
13. Saksena S. Natural history and determinants of disease progression in non alcoholic fatty liver disease: Good and bad news (abstract). Hepatology 2003;38(Suppl 1):232.
14. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of 42 patients for up to 21 years. Hepatology 1990;11:74-80.
15. Abdelmalek M, Ludwig J, Lindor KD. Two cases from the spectrum of nonalcoholic steatohepatitis. J Clin Gastroenterol 1995;20:127-30.
16. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002;37:154-60.
17. Farrell GC. Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region? J Gastroenterol Hepatol 2003;18:124-38.
18. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Harley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-50.
19. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-9.
20. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study. Hepatology 2000;32:689-92.
21. Ong J, Younossi ZM, Reddy V, Price LL, Gramlich T, Mayes J, et al. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl 2001;7:797-801.
22. Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl 2001;7:363-73.
23. Clark JM, Diehl AM. Nonalcoholic fatty liver disease; an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289: 3000-4.
24. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349-54.
25. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of NASH: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-40.
26. Ratziu V, Bonyhay L, Martino VD, Charlotte F, Cavallaro L, Sayegh-Tainturier M, et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002;35:1485-93.